Jesús
San Miguel Izquierdo
Consultor Investigador
Centre Hospitalier Universitaire de Nantes
Nantes, FranciaPublicaciones en colaboración con investigadores/as de Centre Hospitalier Universitaire de Nantes (4)
2023
-
Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
Blood cancer discovery, Vol. 4, Núm. 5, pp. 365-373
2011
-
Consensus recommendations for risk stratification in multiple myeloma: Report of the International Myeloma Workshop Consensus Panel 2
Blood
-
Consensus recommendations for standard investigative workup: Report of the International Myeloma Workshop Consensus Panel 3
Blood
-
Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1
Blood